MiNK Share Price
NASDAQ: INKT | Micro Cap | Healthcare$7.80
+$7.80 (--%) Last updated on 21 Nov, 2026 | 01:54 ISTMiNK Stock Performance
MiNK Share Price Chart
$0.00$0.00
L
H
MiNK Quarterly Profit & Loss
All figures in USD
MiNK Annual Profit & Loss
All figures in USD
MiNK Balance Sheet
All figures in USD Million
MiNK Cash Flow
Annually
All figures in USD Million
Corporate Actions
About MiNK
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.
MiNK Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $11.27 | $7.80 | -25.88% |
Oct 2026 | $12.83 | $10.53 | -16.43% |
Sep 2026 | $11.12 | $12.60 | +15.60% |
Aug 2026 | $11.52 | $10.90 | +4.21% |
Jul 2026 | $11.26 | $10.46 | -10.21% |
Jun 2026 | $12.27 | $11.65 | -4.51% |
May 2026 | $11.90 | $12.20 | +1.16% |
Apr 2026 | $10.29 | $12.06 | +10.64% |
Mar 2026 | $10.32 | $10.90 | -5.63% |
Feb 2026 | $11.70 | $11.55 | -9.77% |
Jan 2026 | $12.80 | $12.80 | +8.84% |
Dec 2025 | $11.21 | $11.76 | +7.06% |
